Functional alterations of the medial frontal gyrus as candidate biomarkers for resilience in major depressive disorder Authors: Feng Li, Qijing Bo, Zhenzhu Chen, Chuanyue Wang, Zhifang Zhang Published: 2026 ABSTRACT BackgroundMajor depressive disorder (MDD) is a prevalent psychiatric condition; however, candidate neural substrates related to resilience to MDD remain unclear.MethodsResting-state functional magnetic resonance imaging (fMRI) data were collected from 113 patients with MDD, 36 unaffected siblings, and 81 healthy controls (HCs). First, degree centrality (DC) analysis was performed to identify group differences. Next, regions showing significant DC differences were used as seeds for whole-brain functional connectivity (FC) analyses. Finally, associations between these significant brain regions and depressive symptom severity were examined separately within each participant group.ResultsDC in the medial frontal gyrus and the right precentral gyrus, as well as FC between the medial frontal gyrus and the right postcentral gyrus, exhibited the pattern: patients with MDD < HCs < unaffected siblings. Correlation analyses revealed no significant relationships between depressive symptom severity and DC or FC values.ConclusionsUnaffected siblings exhibited both the highest DC and the strongest FC related to the medial frontal gyrus. These neuroimaging findings provide further insight into the role of the medial frontal gyrus in potential resilience mechanisms and suggest potential directions for the prevention and treatment of MDD.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12888-026-08267-8. Introduction Major depressive disorder (MDD) is a prevalent psychiatric condition, with a reported lifetime prevalence of approximately 3.4% in China [1]. It is widely recognized as a brain disorder influenced by both genetic and environmental factors [2]. First-degree relatives of individuals with MDD share approximately 50% genetic similarity with affected individuals [3]. Unaffected siblings constitute a particularly informative comparison group because they are more likely to share similar early-life environmental exposures than other first-degree relatives, such as parents and offspring. Investigating similarities and differences in brain function between patients with MDD and their unaffected siblings can help reduce confounding effects from environmental variability, thereby enhancing the identification of potential neurobiological markers associated with genetic risk or resilience [4, 5]. In recent neuropsychiatric research, resilience is increasingly understood not simply as the absence of illness, but as the presence of adaptive mechanisms that enable individuals at high risk to maintain mental health [6]. Within this framework, Frangou [7] further proposed operational definitions to disambiguate resilience-related brain changes from those associated with disease expression and risk. He suggested that brain structural and functional characteristics unique to resilient relatives, when compared with both patients and healthy individuals, can be interpreted as neurobiological correlates of resilience. These characteristics represent adaptive responses that may protect against the manifestation of MDD despite genetic predisposition. Moreover, brain structural and functional features shared by resilient relatives and patients, relative to healthy individuals, define a vulnerability state that is necessary but not sufficient for disease expression. Features unique to patients, relative to both healthy individuals and relatives, reflect mechanisms underlying overt disease expression. To our knowledge, only three studies from the same research group have employed an identical face-matching task to identify resilience-related features in MDD. These studies reported that, compared with both patients with MDD and healthy controls (HCs), first-degree relatives showed significantly increased effective connectivity from the anterior cingulate gyrus (ACC) to the left dorsolateral prefrontal cortex (DLPFC) [8], as well as increased functional connectivity (FC) between the bilateral amygdala and the perigenual anterior cingulate cortex [9, 10]. However, these studies included unaffected siblings, parents, and offspring without separate analyses of unaffected siblings, which may introduce confounding effects related to age and developmental environment. In addition, no study has investigated potential resilience-related functional brain signatures using resting-state functional magnetic resonance imaging (fMRI) data in MDD. Therefore, further research is required to investigate resting-state brain alterations associated with resilience to MDD, with a specific focus on unaffected siblings. In previous resting-state fMRI studies, degree centrality (DC) and FC are two commonly used indices for exploring the neural mechanisms of MDD [11, 12]. DC reflects the importance of a node within the brain network [13], whereas FC characterizes functional associations between different brain regions [14]. More recently, a DC-based FC analysis strategy has been applied to examine functional interactions of brain regions exhibiting DC alterations in patients with MDD. Seed-based FC analyses can be conducted as a follow-up to DC findings to identify region-to-region interactions contributing to the observed DC changes [15, 16]. For example, Li et al. [17] first examined DC differences between patients with MDD and HCs and identified the right posterior cingulate cortex and right precuneus as key regions of the default mode network (DMN). Using these regions as seeds, they further demonstrated that, compared with HCs, patients with MDD exhibited decreased FC between the right precuneus and other DMN regions, including the bilateral orbital medial frontal gyrus, right superior medial frontal gyrus, left precuneus, and left posterior cingulate cortex. However, DC or DC-based FC analyses have not yet been applied to explore potential resilience-related characteristics in MDD. The present study aimed to identify objective neuroimaging markers associated with resilience mechanisms in MDD. Three participant groups were included: patients with MDD, unaffected siblings, and matched HCs. Resting-state fMRI data were acquired for all participants. First, DC analysis was conducted to identify brain regions showing abnormal patterns across the three groups. Second, regions identified through DC analyses were used as seeds to assess FC between these regions and all other brain voxels. Third, DC or FC values from the significant brain regions were extracted, and their associations with depressive symptom severity were evaluated. This study was expected to provide further insight into possible neural mechanisms underlying resilience to MDD and to suggest potential directions for its prevention and treatment. Materials and methods Procedures were approved by the Institutional Review Boards of the Brain Imaging Center of Beijing Normal University and Beijing Anding Hospital, Capital Medical University. All participants provided written informed consent prior to the study. Clinical trial number: not applicable. Subjects This study enrolled 113 patients with MDD, 36 unaffected siblings, and 81 HCs. All patients were recruited from the outpatient department of Beijing Anding Hospital, Capital Medical University. Diagnoses were established using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P) [18], administered independently by two senior psychiatrists to ensure diagnostic consistency. Depressive symptom severity was assessed in all participants using the 17-item Hamilton Depression Rating Scale (HAMD-17) [19]. Inclusion criteria for patients with MDD were as follows: (1) age between 18 and 60 years; (2) completion of at least junior high school education; (3) right-handed Han Chinese ethnicity; and (4) meeting DSM-IV diagnostic criteria for MDD. Exclusion criteria included: (1) meeting diagnostic criteria for other psychiatric disorders (e.g., schizophrenia); (2) severe physical illness or a history of brain trauma; (3) alcohol or substance abuse; (4) contraindications to magnetic resonance imaging (e.g., metal implants); (5) pregnancy or breastfeeding; and (6) receipt of electroconvulsive therapy within six months prior to the current study. Inclusion criteria for unaffected siblings and HCs were identical to criteria (1)–(3) for the patient group, and additionally required that participants did not meet diagnostic criteria for any DSM-IV Axis I or II disorders. Unaffected siblings were required to have at least one sibling diagnosed with MDD, whereas HCs were required to have no family history of Axis I or II disorders. Exclusion criteria for siblings and HCs were identical to those applied to patients. All groups were recruited from the same geographic regions. To reduce the effect of head motion on the results, participants were excluded according to the following criteria: (1) translation > 3 mm or rotation > 3°; and (2) mean framewise displacement (FD) exceeding three standard deviations above the group mean or fewer than 120 valid time points (FD Power < 0.2 mm) [20]. Based on these criteria, 11 patients with MDD, 1 unaffected sibling, and 10 HCs were excluded. The final sample comprised 102 patients with MDD, 35 unaffected siblings, and 71 HCs. All unaffected siblings were recruited from different families. Demographic and clinical characteristics are presented in Table 1. Table 1Demographic and clinical characteristics of patients with MDD, unaffected siblings, and healthy controlsMean ± SDF/χ2 (P)Post hoc (Bonferroni correction)MDDSLHCsMDD vs. SLMDD vs. HCsHCs vs. SLAgea34.21 ± 11.2136.04 ± 12.3134.56 ± 11.890.31(0.737)///Gender(M/F)b46/5614/2129/420.44(0.801)///Education levelb, c18/31/5310/10/155/21/459.30(0.054)///Mean FDa0.15 ± 0.740.17 ± 0.740.12 ± 0.055.88(0.003*)0.1480.1370.003*HAMDa13.40 ± 8.781.91 ± 2.040.82 ± 1.6398.18(< 0.001*)< 0.001*< 0.001*1.000Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controls; FD: framewise displacement, HAMD: 17-item Hamilton depression scaleaThese variables were compared by using two-sample t-testbThese variables were compared by using chi-square testcThe education level was divided into four classes: Junior high school/Senior high school or polytechnic school/ Junior college or bachelor degree or above*P < 0.05 Table 1Demographic and clinical characteristics of patients with MDD, unaffected siblings, and healthy controlsMean ± SDF/χ2 (P)Post hoc (Bonferroni correction)MDDSLHCsMDD vs. SLMDD vs. HCsHCs vs. SLAgea34.21 ± 11.2136.04 ± 12.3134.56 ± 11.890.31(0.737)///Gender(M/F)b46/5614/2129/420.44(0.801)///Education levelb, c18/31/5310/10/155/21/459.30(0.054)///Mean FDa0.15 ± 0.740.17 ± 0.740.12 ± 0.055.88(0.003*)0.1480.1370.003*HAMDa13.40 ± 8.781.91 ± 2.040.82 ± 1.6398.18(< 0.001*)< 0.001*< 0.001*1.000Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controls; FD: framewise displacement, HAMD: 17-item Hamilton depression scaleaThese variables were compared by using two-sample t-testbThese variables were compared by using chi-square testcThe education level was divided into four classes: Junior high school/Senior high school or polytechnic school/ Junior college or bachelor degree or above*P < 0.05 Demographic and clinical characteristics of patients with MDD, unaffected siblings, and healthy controls Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controls; FD: framewise displacement, HAMD: 17-item Hamilton depression scale aThese variables were compared by using two-sample t-test bThese variables were compared by using chi-square test cThe education level was divided into four classes: Junior high school/Senior high school or polytechnic school/ Junior college or bachelor degree or above *P < 0.05 Regarding medication status, 20 patients were medication-naïve, whereas the remaining patients were receiving at least one psychotropic medication. Medications included selective serotonin reuptake inhibitors (SSRIs; n = 44), serotonin–norepinephrine reuptake inhibitors (SNRIs; n = 12), tricyclic or tetracyclic antidepressants (TCAs; n = 3), serotonin receptor antagonists and reuptake inhibitors (n = 5), traditional Chinese medicine (n = 2), low-dose antipsychotics (n = 1), and unspecified medications (n = 15). Imaging data acquisition All imaging data were acquired using a Siemens TIM Trio 3 T MRI system (Siemens, Erlangen, Germany) at the Brain Imaging Center of Beijing Normal University. Structural T1-weighted images (128 volumes) were obtained first, followed by resting-state functional images (240 volumes). During resting-state fMRI scanning, participants were instructed to keep their eyes closed, remain still with minimal head movement, stay awake, and avoid engaging in specific thoughts. Functional images were acquired using an echo-planar imaging (EPI) sequence with the following parameters: axial slices, 33 slices, interleaved acquisition, slice gap = 0.7 mm, repetition time (TR) = 2000 ms, echo time (TE) = 30 ms, flip angle (FA) = 90°, field of view (FOV) = 200 × 200 mm2, matrix size = 64 × 64, slice thickness = 3.5 mm, and voxel size = 3.13 × 3.13 × 4.2 mm³. Structural T1-weighted images were acquired using a sagittal three-dimensional magnetization-prepared rapid gradient echo (MPRAGE) sequence with the following parameters: TR = 2530 ms, TE = 3.39 ms, FA = 7°, FOV = 256 × 192 mm2, matrix size = 192 × 192, slice thickness = 1.33 mm, and voxel size = 1 × 1 × 1.33 mm³. Resting-state fMRI data preprocessing Resting-state fMRI data were preprocessed using DPABI v5.1 software (http://rfmri.org/DPABI) [21]. Preprocessing steps included removal of the first five time points, slice timing correction, realignment, segmentation, coregistration, nuisance covariate regression (including 24 head motion parameters derived from the Friston 24-parameter model [22], white matter signals, cerebrospinal fluid signals, and head motion scrubbing), normalization with resampling to a voxel size of 3 × 3 × 3 mm³, linear detrending, band-pass filtering (0.01–0.1 Hz), and spatial smoothing with a 4 mm full-width at half maximum Gaussian kernel. Global signal regression was not applied because of ongoing methodological debate [23, 24]. In addition, volume-based FD was calculated from realignment parameters to quantify head motion, and mean FD was computed across all volumes for each participant [25]. DC calculation Based on the preprocessed fMRI data, DC values were calculated for each participant using a voxel-wise approach implemented in DPABI v5.1. Following conventional practices reported in the literature [26, 27], the DC value of a voxel was defined as the sum of Pearson correlation coefficients across all possible voxel pairs, with a correlation threshold set at r0 = 0.25, which is the default parameter in DPABI. This threshold is commonly adopted to reduce the contribution of noise-driven weak correlations to voxel centrality estimation [28]. Higher DC values indicate greater importance of a voxel within the brain network [29]. For each participant, the resulting DC map was transformed into a z-score map before second-level analyses were conducted [30]. Seed-based FC analyses Seed-based FC analyses were conducted using DPABI v5.1. Consistent with previous studies [16, 31], brain regions showing significant DC differences were selected as seeds. First, the time series of all voxels within each seed region were extracted and averaged to obtain a mean seed time series. Second, Pearson correlation coefficients were calculated between the mean seed time series and the time series of all other brain voxels, generating individual FC maps. Finally, Fisher r-to-z transformation was applied to the FC maps to generate z-score maps for subsequent second-level analyses [32]. Statistical analyses Demographic and clinical differences among patients with MDD, unaffected siblings, and HCs were analyzed using IBM SPSS Statistics Desktop 20.0. Differences in gender and education level were examined using chi-square tests, whereas age and HAMD-17 total scores were assessed using one-way analysis of variance (ANOVA). Statistical significance was defined as P < 0.05 (two-tailed). Using Statistical Parametric Mapping (SPM12, Welcome Department of Cognitive Neurology, London, UK), ANCOVA was performed to compare DC and FC values among patients with MDD, unaffected siblings, and HCs. Age, gender, education level, and mean FD were included as covariates. Family-wise error (FWE) correction was applied at the voxel level to correct for multiple comparisons, with the significance threshold set at PFWE−corrected < 0.05. When a significant brain region was identified, DC or FC values for all voxels within that region were extracted and averaged. Post hoc analyses were then performed on the mean DC or FC values to determine the group comparisons contributing to the observed differences, using a significance threshold of P < 0.05 with Bonferroni correction, as implemented in SPSS 20.0. DC and FC comparisons were restricted to a predefined gray matter mask generated using the same procedure described in our previous study [33]. Additionally, significant brain regions were assigned to large-scale brain networks based on the Yeo 7-network template [34] to determine their network affiliations. Finally, to examine associations between abnormal DC or FC values and depressive symptom severity, Spearman correlation analysis was performed to evaluate relationships between DC or FC values and HAMD-17 total scores within each group, with statistical significance defined as P < 0.05 (two-tailed). Results Demographic and clinical data No statistically significant differences were observed among the groups in age, gender, or education level (all P > 0.05), with the exception of the HAMD-17 total score (P < 0.001) and mean FD (P = 0.003) (Table 1). Post hoc analyses indicated that patients with MDD had significantly higher HAMD-17 scores than both unaffected siblings and HCs, and unaffected siblings had significantly higher mean FD than HCs (all P < 0.05). DC analyses Significant group differences in DC were identified in the medial frontal gyrus and the right precentral gyrus. Post hoc analyses demonstrated that unaffected siblings exhibited higher DC values than both patients with MDD and HCs in these regions (all P < 0.001). HCs showed higher DC values than patients with MDD in the right precentral gyrus (P = 0.037), whereas no significant difference was observed between these two groups in the medial frontal gyrus (P = 0.304) (Fig. 1; Table 2). DC maps for each group are presented in Supplementary Fig. S1. Fig. 1Comparison of degree centrality among patients with MDD, unaffected siblings, and healthy controls. In each panel, the left side shows the significant brain region, and the right side presents post hoc analysis results Comparison of degree centrality among patients with MDD, unaffected siblings, and healthy controls. In each panel, the left side shows the significant brain region, and the right side presents post hoc analysis results Table 2Between-group differences in degree centrality and functional connectivity among patients with MDD, unaffected siblings, and healthy controlsIndexBrain regionHemispherePeak MNI coordinatesPeak F valuesCluster sizeVoxel-level PFWEPost hoc analyses (Bonferroni correction)Degree centralityMedial FrontalGyrusLeft/Right-3 -27 6017.76170.008*MDD < HCs, P = 0.304MDD < SL, P < 0.001*HCs < SL, P < 0.001*PrecentralRight42 − 9 5715.8770.035*MDD < HCs, P = 0.037*MDD < SL, P < 0.001*HCs < SL, P = 0.003*Functional connectivityaPostcentralRight39 − 33 6315.7930.039*MDD < HCs, P = 0.001*MDD < SL, P < 0.001*HCs < SL, P = 0.205Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controlsaUsing the medial frontal gyrus as seed*P < 0.05; Table 2Between-group differences in degree centrality and functional connectivity among patients with MDD, unaffected siblings, and healthy controlsIndexBrain regionHemispherePeak MNI coordinatesPeak F valuesCluster sizeVoxel-level PFWEPost hoc analyses (Bonferroni correction)Degree centralityMedial FrontalGyrusLeft/Right-3 -27 6017.76170.008*MDD < HCs, P = 0.304MDD < SL, P < 0.001*HCs < SL, P < 0.001*PrecentralRight42 − 9 5715.8770.035*MDD < HCs, P = 0.037*MDD < SL, P < 0.001*HCs < SL, P = 0.003*Functional connectivityaPostcentralRight39 − 33 6315.7930.039*MDD < HCs, P = 0.001*MDD < SL, P < 0.001*HCs < SL, P = 0.205Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controlsaUsing the medial frontal gyrus as seed*P < 0.05; Between-group differences in degree centrality and functional connectivity among patients with MDD, unaffected siblings, and healthy controls Medial Frontal Gyrus MDD < HCs, P = 0.304 MDD < SL, P < 0.001* HCs < SL, P < 0.001* MDD < HCs, P = 0.037* MDD < SL, P < 0.001* HCs < SL, P = 0.003* MDD < HCs, P = 0.001* MDD < SL, P < 0.001* HCs < SL, P = 0.205 Note: MDD: patients with major depressive disorder; SL: unaffected siblings; HCs: healthy controls aUsing the medial frontal gyrus as seed *P < 0.05; FC analyses The medial frontal gyrus and the right precentral gyrus were each used as seed regions. When the medial frontal gyrus was selected as the seed, a significant group difference was detected in the right postcentral gyrus. Post hoc analyses revealed that both unaffected siblings and HCs exhibited higher FC than patients with MDD (all P < 0.001). Unaffected siblings also showed higher FC than HCs; however, this difference did not survive correction for multiple comparisons (P = 0.205) (Fig. 2; Table 2). FC maps for each group are shown in Supplementary Fig. S2. When the right precentral gyrus was used as the seed, no significant group difference was identified (P > 0.05). Fig. 2Comparison of functional connectivity among patients with MDD, unaffected siblings, and healthy controls. In each panel, the left side shows the significant brain region, and the right side presents post hoc analysis results Comparison of functional connectivity among patients with MDD, unaffected siblings, and healthy controls. In each panel, the left side shows the significant brain region, and the right side presents post hoc analysis results In addition, all brain regions showing significant DC and FC differences were located within the sensorimotor network (SMN) (Fig. 3). No significant correlation was observed between depressive symptom severity and DC or FC values within any group (all P > 0.05). Fig. 3Mapping of significant brain regions identified in degree centrality and functional connectivity analyses to the sensorimotor network. The transparent blue area represents the sensorimotor network, whereas the yellow area denotes the significant brain region Mapping of significant brain regions identified in degree centrality and functional connectivity analyses to the sensorimotor network. The transparent blue area represents the sensorimotor network, whereas the yellow area denotes the significant brain region Discussion In this study, DC and FC analyses were applied to investigate potential resilience-related neural characteristics in MDD. The results showed that unaffected siblings exhibited the highest DC values in the medial frontal gyrus and the right precentral gyrus, together with the strongest FC between the medial frontal gyrus and the right postcentral gyrus. These findings suggest that functional alterations of the medial frontal gyrus may be associated with resilience to MDD. Significant group differences in DC were observed in both the medial frontal gyrus and the right precentral gyrus. Functionally, the medial frontal gyrus plays a key role in decision-making and executive control [35], whereas the precentral gyrus primarily supports sensorimotor processing [36]. Abnormalities in these regions have been consistently reported in MDD. For example, a previous study [37] including patients with MDD, unaffected siblings, and HCs showed that patients with MDD exhibited increased fractional amplitude of low-frequency fluctuations (fALFF) in the medial frontal gyrus relative to both unaffected siblings and HCs, whereas the latter two groups showed comparable values [37]. In the same study, patients with MDD also showed reduced fALFF in the right precentral gyrus compared with HCs [37], although opposite findings have also been reported [38]. Consistent with these observations, Iwabuchi et al. [39] reported increased regional homogeneity (ReHo) in the medial prefrontal gyrus in patients with MDD relative to HCs. Taken together with the present findings, these results reinforce the central role of these regions in MDD. Importantly, unaffected siblings showed the highest DC values relative to both patients with MDD and HCs, indicating that compensatory or adaptive neural processes may support resilience. This pattern aligns with the view that resilience reflects active neural adaptation rather than the simple lack of pathology. When such compensatory capacity declines toward or below levels observed in healthy individuals, the risk of developing MDD may increase in unaffected siblings, consistent with the concept that disruption of resilience-related brain mechanisms can precede illness onset [7, 40]. FC between the medial frontal gyrus and the right postcentral gyrus followed a similar pattern, with the lowest values in patients with MDD, intermediate values in HCs, and the highest values in unaffected siblings. Both regions are core components of sensorimotor processing systems [18] and contribute to emotion regulation, particularly interoceptive attention [40, 41]. Both regions are located within the SMN, and the present results indicate enhanced SMN connectivity in unaffected siblings. Large-scale studies have consistently reported reduced average FC within the SMN in patients with MDD compared with HCs [42, 43], although the specific regions showing alterations vary across studies. For instance, Samara et al. [44] reported increased FC between the paracentral lobule and the anterior portion of the anterior cingulate cortex, together with reduced FC between the ventromedial prefrontal cortex and the inferior parietal lobule, in both patients with MDD and unaffected first-degree relatives. Collectively, these findings highlight the role of the SMN in MDD pathophysiology and highlight its association with sensorimotor integration and affective regulation. The altered functional organization of the medial frontal gyrus observed in unaffected siblings provides further clues regarding a key neural substrate of resilience. These results support the view that the SMN, particularly the medial frontal gyrus, may serve as a candidate biomarker and therapeutic target in MDD. No significant association was detected between depressive symptom severity and DC or FC values in any group. These negative findings were consistent with previous reports [37, 44] and suggested that the candidate resilience-related neuroimaging characteristics identified here may represent relatively stable traits rather than state-dependent markers influenced by current symptom severity. Although the present study provides additional insight into potential neurobiological markers of resilience to MDD, several limitations should be acknowledged. The cross-sectional design precludes causal inference, and the absence of longitudinal follow-up and direct genetic data limits interpretation. Nevertheless, indirect support is provided by previous longitudinal and genetic studies. For example, one longitudinal study reported that, after one year of comparable antidepressant treatment, regional brain activity and FC within the SMN increased in patients with MDD and were significantly associated with improvement in depressive symptoms [45]. These findings suggest that the SMN may represent an important neural foundation for treatment response and recovery, expressing features related to resilience. In addition, a genetic study reported increased intranetwork SMN connectivity during rest in patients with MDD relative to HCs, and in HCs this connectivity showed significant positive associations with polygenic risk scores for MDD [46]. This pattern indicates that resting-state FC within the SMN may reflect a neuroadaptive response in individuals at elevated genetic risk who remain asymptomatic. Together, these observations provide converging evidence that the findings reported here offer new insight into potential neurobiological mechanisms underlying resilience in MDD. Several additional limitations warrant consideration. First, although the overall sample size was relatively large (N = 208), group sizes were unequal. Demographic variables were well matched across groups, and sensitivity analyses were conducted to assess the effect of sample imbalance. After randomly selecting equal numbers of patients with MDD and HCs to match the unaffected siblings on age, gender, and education level, the main findings remained consistent (Supplementary Fig. S3), indicating stability of the results. Nevertheless, the absence of an independent validation cohort and suitable public datasets limits assessment of generalizability. Future studies should recruit more balanced samples, particularly increasing the number of unaffected siblings. Second, most patients with MDD had received pharmacological treatment prior to participation, and medication effects cannot be fully excluded [47]. Because several patients were receiving multiple classes of medication and detailed dosage information was unavailable, medication status could not be included as a covariate. However, analyses restricted to medication-naïve patients and matched unaffected siblings and HCs yielded similar results (Supplementary Fig. S4), suggesting that the findings are relatively robust. Future studies recruiting exclusively medication-naïve patients would further clarify medication-independent effects. Third, the absence of direct clinical measures of resilience, genetic data, and longitudinal follow-up limits interpretation. Given these limitations, unaffected siblings in the present study can only be considered as a relatively non-affected comparison group with potential resilience related traits rather than a confirmed resilient population. Future studies should incorporate validated resilience scales to explicitly define and characterize resilient individuals. And longitudinal and genetically informed studies are therefore required to further validate and extend the present findings. Conclusion In conclusion, unaffected siblings exhibited the highest DC and the strongest FC of the medial frontal gyrus. These results suggest that functional alterations of the medial frontal gyrus may represent candidate biomarkers of resilience in MDD. Enhanced medial frontal gyrus activity may reflect a compensatory neural mechanism in unaffected siblings that contributes to protection against the development of MDD. Together, these findings advance understanding of potential neural basis of resilience in MDD and may inform the identification of early predictive markers or potential intervention targets. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1